ARCHIVES

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

This article is from The Cancer Letter archive.

Vol. 08 No. 08 | February 19, 1982

Download PDF Visit The Full Archive

Related Articles

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

FDA Committee to Discuss Policy On Combinations

January 7, 1977

In Brief: DeVita Changes His Mind, Agrees To Head Treatment DIV; Contracts Chief Carl Fretts Moves Up To NIH

October 4, 1974

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009